ClinicalTrials.gg
RecruitingNCT06058754Go:OTUpdated Sep 28, 2023

Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT Trial)

An interventional study of The ADAPT Program and UOT in Chronic Condition, Chronic Disease and Chronic Conditions, Multiple, sponsored by Parker Research Institute. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-28.

Primary conditionMultiple Chronic ConditionsRegistry: Chronic DiseaseReclassifiedWhy we changed it
Registry
Chronic Disease — the first condition term the registry derived for this study.
ClinicalTrials.gg
Multiple Chronic Conditions
Why
  1. Chronic Disease is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Multiple Chronic Conditions, a narrower term within Chronic Disease.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Parker Research Institute · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This trial aims to evaluate the ADAPT Program in terms of efficacy, process and cost-efficacy compared to usual occupational therapy (UOT) in people with decreased ability to perform activities of daily living (ADL) following chronic conditions. As both the ADAPT Program and UOT are targeted improvements in ADL ability, the primary objective of this trial is to assess equivalence between the ADAPT Program and UOT on changes in ADL ability as measured with the Assessment of Motor and Process Skills (AMPS).

Read the detailed description

Background: The number of people living with chronic conditions limiting the ability to perform activities of daily living (ADL) tasks is increasing. Occupational therapists are trained to deliver interventions to improve ADL ability, e.g. by adapting and adjusting daily routines and physical environments. Municipality occupational therapy (OT) interventions are usually delivered as one-to-one sessions in the client´s home. While this intervention format might be effective in improving ADL ability, a group-based intervention format might be as effective but more cost-effective and hold other secondary gains. Guided by the British Medical Research Council's guidance (MRC) on how to develop and evaluate complex interventions, the ADAPT Program, a peer-exchange group-based program, was developed, piloted, and evaluated for its functioning and feasibility in municipality settings. These studies provided initial evidence for the ADAPT Programs effectiveness in improving ADL ability and suggests gains as improved well-being. Hence, the current phase concerns a full-scale evaluation of the ADAPT Program including evaluation of effectiveness, processes and cost-effectiveness.

Material and Methods: The randomized controlled trial (RCT), initiated with an external pilot (n=12), will include 130 home dwelling persons with decreased ADL ability following chronic conditions. Participants are randomized to either ADAPT Program (experimental) or usual OT (control).

Primary outcome: Observed ADL motor ability measured with the Assessment of Motor and Process Skills (AMPS).

Secondary outcomes: Observed ADL process ability measured with the AMPS; patient reported ADL task Performance and Satisfaction measured with the ADL-Interview (ADL-I, Performance and Satisfaction scores); Well-being assessed with the World Health Organisation-Five Well Being Index (WHO-5); Health-related Quality of Life assessed with the European Quality of Life - 5 Dimensions (EQ-5D).

Exploratory outcomes include patient reported changes, using transition scales to evaluate participants´ experience of a) changed ADL task performance and satisfaction, b) changed problem-solving skills, c) changed quality of life, d) changed global health, e) changed needs for assistance. Finally, participants are to rate their overall experience of the allocated occupational therapy intervention.

Data collection: Effectiveness and cost-effectiveness data are collected at baseline and post intervention i.e., 3-months (week 12) and 6-months (week 26) from baseline. Costs will be estimated based on micro costing and national registries. Effects will be Quality Adjusted Life Years and changes in AMPS ADL motor ability. Process evaluation data will be collected using registration forms and semi-structured qualitative interviews.

02

Conditions studied

  • Chronic Condition
  • Chronic Disease
  • Chronic Conditions, Multiple

Browse trials for

Keywords

  • Occupational therapy
  • ADL
  • Adaptation
  • Chronic condition
  • Peer-exchange
  • group-based
03

In context

Multiple Chronic Conditions Reclassified

89 studies on the registry are indexed under Multiple Chronic Conditions; 16 are open to participants now.

This study's planned enrollment of 130 is close to the median of 128 across 71 interventional studies indexed under Multiple Chronic Conditions.

Browse Multiple Chronic Conditions studies →

Lead sponsor

Parker Research Institute is the lead sponsor of 13 studies on the registry; 3 are open to participants now.

Compared within Multiple Chronic Conditions, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Chronic Disease. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ one year since medical diagnosed with one or more chronic conditions.
  • Lives in own home.
  • Experience ADL task performance problems.
  • Show ADL motor ability measures \<1.50 logits on the AMPS ADL motor skill scale (indicate increased effort during ADL task performance).
  • Communicate independently and relevantly orally and in writing.
  • Willing and interested in attending occupational therapy interventions focused on improving ADL task performance.

Exclusion criteria

Exclusion criteria:

  • ADL process ability measures \<0.00 indicating that the person is unlikely to profit from educational programs focused on using adaptational strategies.
  • Personal ADL (PADL) problems with acute need for help.
  • Mental illness and/or other acute (\<3 months) conditions effecting ADL task performance significantly.
  • Significant communication barriers (significant cognitive deficits, -aphasia, -hearing loss, -dyslexia and/or -language barriers).
  • Known substance abuse.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    ADAPT Program

    The ADAPT Program is a structured and individualized group-based program

    Behavioral: The ADAPT Program

  • Active comparator
    Usual Occupational Therapy (UOT)

    UOT is delivered by one occupational therapist in the clients homes or local environments. .

    Behavioral: UOT

Interventions

  • BehavioralThe ADAPT Program

    The ADAPT Program is a structured and individualized 10-week group-based program, in which two occupational therapists teach groups of people, the skills of problem-solving more efficiently as means to overcome ADL task performance problems. The ADAPT Program 3.0 includes 2 individual two-hour sessions (sessions 1 and 10) conducted in the clients homes and eight two-hour group-based sessions (sessions 2-9). Moreover, two booster sessions (sessions 11 and 12) are delivered to support sustainable gains after termination of the 10-week ADAPT Program 3.0

    Also known as: Adaptation, Compensatory, occupational therapy, group-based, peer-exchange, problem-solving

  • BehavioralUOT

    UOT is delivered by one occupational therapist. Sessions are individualised and focused on improving ADL ability e.g. by practicing the performance of ADL task or adjusting home environments. UOT typically includes 7 one-to-one sessions of 60 minutes, delivered over a 10-week period in the clients´ homes. The dose is however not fixed but based on the occupational therapists´ clinical judgement in collaboration with the individual client

    Also known as: Usual occupational therapy

06

What researchers measure

Primary outcomes

  1. Change in observed ADL motor ability, Assessment of Motor and Process Skills (AMPS)

    Observation-based ADL motor ability (reflecting physical effort and independence ). Linear measures of ADL motor ability generated using Rasch measurement models. Higher scores mean better ADL ability

    Time frame: week 12

Secondary outcomes

  1. Change in observed ADL motor ability, using AMPS

    Observation-based ADL motor ability (reflecting physical effort and independence ). Linear measures of ADL motor ability generated using Rasch measurement models. Higher scores mean better ADL ability

    Time frame: week 26

  2. Change in observed ADL process ability, using AMPS

    Observation-based ADL process ability (reflecting efficiency, safety and independence). Linear measures of ADL process ability generated using Rasch measurement models. Higher scores mean better ADL ability

    Time frame: week 12

  3. Change in observed ADL process ability, using AMPS

    Observation-based ADL process ability (reflecting efficiency, safety and independence). Linear measures of ADL process ability generated using Rasch measurement models. Higher scores mean better ADL ability

    Time frame: week 26

  4. Change in self-reported ADL ability, using the ADL-Interview (ADL-I), Performance scale

    Self-reported ability to perform ADL tasks, based on interview. Linear measures of ADL ability generated using Rasch measurement models. Higher scores mean better ADL ability

    Time frame: week 12

  5. Change in self-reported ADL ability with ADL-I, Performance scale

    Self-reported ability ot perform ADL tasks, based on interview. Linear measures of ADL ability generated using Rasch measurement models. Higher scores mean better ADL ability

    Time frame: week 26

  6. Change in self-reported satisfaction with ADL ability, using ADL-I, Satisfaction scale

    Self-reported satisfaction with ADL task performance, based on interview. Linear measures of ADL ability generated using Rasch measurement models. Higher scores means higher satisfaction

    Time frame: week 12

  7. Change in self-reported satisfaction with ADL ability, using the ADL-Interview (ADL-I), Satisfaction scale

    Self-reported satisfaction with ADL task performance, based on interview. Linear measures of ADL ability will be generated using Rasch measurement models. Higher scores means higher satisfaction

    Time frame: week 26

  8. Well-being, using the World Health Organisation- Five Well-Being Index (WHO-5)

    Participants are asked to rate well being in regard to five questions. Response options are scored on a 6-point scale in which 0=at no time to 0=all the time. Lower scores are lower well-being

    Time frame: week 12

  9. Well-being, using The World Health Organisation- Five Well-Being Index (WHO-5)

    Participants are asked to rate well being in regard to five questions. Response options are scored on a 6-point scale in which 0=at no time to 0=all the time. Lower scores are lower well-being

    Time frame: week 26

  10. Quality of life, using the EuroQoL 5 dimensions (EQ-5D)

    Participants are asked to rate 5 aspects of health-related quality of life Quality of life in regard to five items scores on a 5 point likert scale from I am not/have none to I have extreme/i cannot

    Time frame: week 12

  11. Quality of life, using EQ-5D

    Participants are asked to rate 5 aspects of health-related quality of life Quality of life in regard to five items scores on a 5 point likert scale from I am not/have none to I have extreme/i cannot

    Time frame: week 26

Other outcomes

  1. Perceived change in ADL task performance, TRANS-Questionnaire

    Participants are asked about their experienced change in a) performance of ADL tasks and b) satisfaction witt their ADL ability following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worse' to 'markedly better'

    Time frame: week 12

  2. Perceived change in ADL task performance, TRANS-Questionnaire

    Participants are asked about their experienced change in a) performance of ADL tasks and b) satisfaction witt their ADL ability following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worse' to 'markedly better'

    Time frame: week 26

  3. Perceived change in problem-solving skills, TRANS-Questionnaire

    Participants are asked about their experienced change in a) identifying daily task performance problems and b) the ability to solve task performance problems following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worsened' to 'markedly better'

    Time frame: week 12

  4. Perceived change in problem-solving skills, TRANS-Questionnaire

    Participants are asked about their experienced change in a) identifying daily task performance problems and b) the ability to solve task performance problems following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worsened' to 'markedly better'

    Time frame: week 26

  5. Perceived change in Quality of Life, TRANS-Questionnaire

    Participants are asked about their experienced change in a) overall functioning, b) mental well-being, c) physical well-being and d) social well-being following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly bigger' to 'markedly less'

    Time frame: week 12

  6. Perceived change in Quality of Life, TRANS-Questionnaire

    Participants are asked about their experienced change in a) overall functioning, b) mental well-being, c) physical well-being and d) social well-being following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly bigger' to 'markedly less'

    Time frame: week 26

  7. Perceived change in global health, TRANS-Questionnaire

    Participants are asked about their experienced change in global health following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worse' to 'markedly better'

    Time frame: week 12

  8. Perceived change in global health, TRANS-Questionnaire

    Participants are asked about their experienced change in global health following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly worse' to 'markedly better'

    Time frame: week 26

  9. Perceived change in assistance needed, TRANS-Questionnaire

    Participants are asked about their experienced change in needing assistance in a) findings ways to ease task performance, b) accepting my chronic condition, c) managing symptoms following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly bigger' to 'markedly less'

    Time frame: week 12

  10. Perceived change in assistance needed, TRANS-Questionnaire

    Participants are asked about their experienced change in needing assistance in a) findings ways to ease task performance, b) accepting my chronic condition, c) managing symptoms following occupational therapy intervention. Response options are scored on a 7-point likert scale from 'markedly bigger' to 'markedly less' less

    Time frame: week 26

  11. Overall experience of the occupational therapy intervention

    Participants are asked to rate their experience on a 5 point Likert scale ranging from "excellent' to 'very poor'

    Time frame: week 12

07

Study locations

1 of 1 sites recruiting
  • The Parker Research Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Frederiksberg, Denmark
    Frederiksberg, 2000, Denmark
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06058754
Lead sponsor
Parker Research Institute
Collaborators
Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre Kommune), Den Kommunale Kvalitetsudviklingspulje, Lundbeckpuljen, Oak Foundation, Tværspuljen
Responsible party
Eva Ejlersen Wæhrens (Senior researcher, Associate Professor, Parker Research Institute) — Principal investigator
First posted
Sep 28, 2023
Start date
Sep 4, 2023
Primary completion
Sep 27, 2024 (estimated)
Completion
Dec 6, 2024 (estimated)
Last update
Sep 28, 2023

Study contacts

Cecilie von Bülow, PhD
Contact
Cecilie.von.bulow@regionh.dk
38164147
Eva Wæhrens, Professor
Contact
eva.elisabet.waehrens@regionh.dk
38164166
Cecilie von Bülow, PhD
principal investigator · Parker Institute, Bispebjerg and Frederiksberg Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion